BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20981426)

  • 1. Circulating procoagulant microparticles in cancer patients.
    Thaler J; Ay C; Weinstabl H; Dunkler D; Simanek R; Vormittag R; Freyssinet JM; Zielinski C; Pabinger I
    Ann Hematol; 2011 Apr; 90(4):447-53. PubMed ID: 20981426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microparticles and risk of venous thromboembolism.
    Bucciarelli P; Martinelli I; Artoni A; Passamonti SM; Previtali E; Merati G; Tripodi A; Mannucci PM
    Thromb Res; 2012 May; 129(5):591-7. PubMed ID: 21908018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
    van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
    Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
    Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
    Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
    Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
    Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
    Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.
    Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P
    Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Di Micco P; Iannuzzo M; Lecumberri R; Guijarro R; Madridano O; Monreal M;
    Thromb Haemost; 2008 Nov; 100(5):905-11. PubMed ID: 18989537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of circulating microparticles for venous thromboembolism in cancer patients.
    Thaler J; Ay C; Pabinger I
    Hamostaseologie; 2012; 32(2):127-31. PubMed ID: 21792463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High concentrations of procoagulant microparticles in the cerebrospinal fluid and peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome.
    Huang M; Hu YY; Dong XQ
    Surg Neurol; 2009 Nov; 72(5):481-9; discussion 489. PubMed ID: 19328537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I
    J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation.
    Ederhy S; Di Angelantonio E; Mallat Z; Hugel B; Janower S; Meuleman C; Boccara F; Freyssinet JM; Tedgui A; Cohen A
    Am J Cardiol; 2007 Sep; 100(6):989-94. PubMed ID: 17826384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating procoagulant microparticles in patients with venous thromboembolism.
    Ay C; Freyssinet JM; Sailer T; Vormittag R; Pabinger I
    Thromb Res; 2009 Mar; 123(5):724-6. PubMed ID: 18995886
    [No Abstract]   [Full Text] [Related]  

  • 18. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus.
    Morel O; Hugel B; Jesel L; Lanza F; Douchet MP; Zupan M; Chauvin M; Cazenave JP; Freyssinet JM; Toti F
    Thromb Haemost; 2004 Feb; 91(2):345-53. PubMed ID: 14961163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis.
    Ye R; Ye C; Huang Y; Liu L; Wang S
    Thromb Res; 2012 Aug; 130(2):253-8. PubMed ID: 22099707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.